Amersham, GE merger on track for April

Related tags Ge healthcare European union Amersham

General Electric's €8.1 billion acquisition of the UK's Amersham
was approved by the European Union yesterday, after it concluded
that the deal would not create a monopoly in Europe's medical
imaging market.

The concern had been that GE would be able to bundle its instruments with Amersham's imaging agents and squeeze other suppliers out of the market. Similar bundling issues caused the EU to block GE's proposed merger with Honeywell International in 2001.

The US antitrust authorities gave their backing to the deal last month, and the two companies are now expecting to seal the knot in April.

Once completed, Amersham will join another recent acquisition - Finland's Instrumentarium -as part of a new GE Healthcare Technologies division, specialising in medical imaging and diagnostics. It will be headquartered in the UK and headed by Amersham chief executive Sir Bill Castell.

Amersham Biosciences, which makes instruments and tools used in drug discovery as well as protein separation equipment for manufacturing, will operate as a unit of GE Healthcare Technologies.

There has been speculation that Biosciences may in time be spun out as it covers industries that are new for GE. However, GE's chief executive, Jeffrey Immelt, has repeatedly stressed that the company is firmly committed to the drug industry and will both retain the units and add to them.

Related news

Show more

Related products

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 09-Jun-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us

Products

View more

Webinars